Opinion Article, J Genetic Gene Ther Vol: 7 Issue: 1

Gene Therapy Preventative Methods to regulate the Progression

Catalano Pijnenburg^*

¹Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands

*Corresponding Author: Catalano Pijnenburg
Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands
E-mail: pijnenburg.c@gmail.com

Received date: 04 March, 2023, Manuscript No. JGGT-23-95798;

Editor assigned date: 06 March, 2023, PreQC No. JGGT-23-95798 (PQ);

Reviewed date: 20 March, 2023, QC No. JGGT-23-95798;

Revised date: 27 March, 2023, Manuscript No. JGGT-23-95798 (R);

Published date: 06 April, 2023 DOI: 10.4172/Jggt.1000141.

Citation: Pijnenburg C (2023) Gene Therapy Preventative Methods to regulate the Progression . J Genetic Gene Ther 7:1.

Abstract

Description

Gene therapy is a rapidly developing field that holds significant potential for treating a wide range of genetic disorders. However, similar to any medical intervention, it also carries potential risks. The prevention of gene therapy is additionally an essential consideration that requires careful balance between the potential benefits and potential harms.

There are several ways to prevent gene therapy from harming patients. Some of the most important are as follows:

Conducting thorough preclinical testing

Before any new gene therapy it is tested in humans, extensive preclinical testing is required in animals. This testing is necessary to assess the safety and efficacy of the therapy, as well as to identify any potential toxicities or side effects. In the laboratory and in live experiments should be included in preclinical testing, as well as doseranging studies to determine the optimal dose for human testing.

Adhering to ethical guidelines

Gene therapy research must adhere to strict ethical guidelines to ensure the protection of human subjects. These guidelines include obtaining patients' informed consent, ensuring that the benefits of the therapy compensate for the dangers, and minimizing harm to participants. Ethical oversight is essential in preventing gene therapy from being used for inappropriate or harmful purposes.

Using safe and effective delivery methods

One of the biggest challenges in gene therapy is delivering the therapeutic gene to the accurate cells in the body. There are several delivery methods available, including viral vectors, non-viral vectors, and physical methods such as electroporation. Each of these methods has its individual advantages and disadvantages, and choosing the most appropriate method it is essential in preventing harm to patients.

Monitoring patients for adverse effects

After gene therapy it has been administered to a patient, it is important to monitor them closely for any adverse effects. This includes monitoring for both immediate and long-term side effects, as well as assessing the efficacy of the therapy. Regular monitoring can help to identify any potential safety difficulties and allow for timely intervention if necessary.

Ensuring proper regulation and oversight

Regulation and oversight are significant in ensuring the safety and efficacy of gene therapy. Regulatory agencies such as the US Food and Drug Administration (FDA) have strict regulations for gene therapy research and recognition, and it is essential to adherence these regulations. Oversight by independent committees, such as Institutional Review Boards (IRBs) and Data Safety Monitoring Boards (DSMBs), can also help to identify any potential safety difficulty and ensure that appropriate measures are implemented.

Irrespective of the risks, gene therapy has the potential to transform the treatment of genetic disorders. In recent years, several gene therapies have been approved for use in the US and other countries, including therapies for inherited retinal disorders, spinal muscular atrophy, and specific types of leukemia. However, these therapies additionally demonstrated the importance of maintaining vigilance in order to protect patients from adverse effects. For example, the importance of safety monitoring is the case of AAV gene therapy for hemophilia A. In 2020, several patients in a clinical trial experienced liver toxicity after receiving high doses of the therapy. The trial failed, and the FDA implemented a therapeutic halt on all additional investigations of the therapy, emphasizing the importance of continuing safety evaluation and oversight.

Another example is the use of CRISPR modification of genes technique, which has the potential to accurate genetic mutations that cause diseases. However, Risks have been contained about the potential for off-target effects, where the gene editing tool may inadvertently cut DNA at unintended locations in the genome. While progress has been produced in improving the specificity of CRISPR, continued investigation is required to ensure that the technology is safe and effective.